novo nordisk cuts prices for its glp-1 drugs. Just Took a Big Swing, Slashing Drug Prices. Will It Pay Off the Healthcare Giant? Novo, Lilly's shares drop as

Projected Users and Market Size Evolution Numerous analysts have published projections on the future use of GLP-1RAs, with all forecasting demand to grow significantly, driven by a combination of factors that include: Increasing Prevalence of Obesity: The number of people living with obesity (BMI of over 30) has tripled since 1975 to c.760m people in 2020

doi: 10.1016/j.urology.2009.09.024 [DOI] [PubMed] [Google Scholar] 9.Sorensen MD Kahn AJ Reiner AP, et al

Dextran sulfate sodium colitis study Wild-type mice (812 weeks of age) were allowed ad libitum access to drinking water containing 1.5%2% dextran sulfate sodium (DSS, MW = 36,00050,000

"DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case-Control Study"

& Bisaga, A

WEIGHT-LOSS DRUGS NOW LINKED TO CANCER PROTECTION IN WOMEN, MAJOR NEW STUDY REVEALS According to a press release, the real-world retrospective study included 12,112 patients with the following types of obesity-related cancers, ranging from stage 1 to stage 3